V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280011657 | 280009018 | 1.5 | null | Neo-adjuvant (N) | 2019-07-10 | 2019-08-14 | Cetuximab+Cisplatin+FU (> Cycle 2) | null | null | 280028006 | CETUXIMAB + CISPLATIN + FU |
| 280011658 | 280005782 | 1.7 | 86.4 | Neo-adjuvant (N) | 2017-02-12 | 2017-02-17 | CARBOPLATIN + PACLITAXEL | 02 | N | 280028075 | CARBOPLATIN + PACLITAXEL |
| 280011659 | 280005787 | 0 | 82.4 | Palliative (P) | 2011-09-27 | 2014-01-15 | GEMCITABINE | N | N | 280028086 | GEMCITABINE |
| 280011660 | 280009032 | 1.81 | 116.5 | Palliative (P) | 2018-03-06 | 2018-07-23 | Irinotecan + Temozolomide | 02 | N | 280028098 | VAI |
| 280011661 | 280005800 | 1.66 | 73.7 | Adjuvant (A) | null | 2014-02-19 | Doxorubicin + Ifosfamide | N | N | 280028141 | DOXORUBICIN + IFOSFAMIDE |
| 280011662 | 280005803 | 1.59 | 62.3 | Palliative (P) | 2014-11-08 | 2015-07-17 | Cetuximab+Cisplatin+FU (> Cycle 2) | 2 | N | 280028146 | CETUXIMAB + CISPLATIN + FU |
| 280011663 | 280005809 | 1.68 | 75 | Palliative (P) | 2016-08-29 | 2016-08-29 | EURO-EWING | Y | N | 280028152 | EURO-EWING |
| 280011664 | 280005816 | null | null | Palliative (P) | 2018-08-30 | 2018-09-25 | Etoposide + Ifosfamide (3 days) | N | N | 280028182 | ETOPOSIDE + IFOSFAMIDE |
| 280011665 | 280010600 | 1.61 | 77 | Palliative (P) | 2015-05-31 | 2015-05-31 | EW EuroEwing 99 : VIDE | 02 | N | 280028183 | EURO-EWING |
| 280011666 | 280005826 | 0 | 62.8 | Palliative (P) | 2017-09-07 | 2017-09-08 | Irinotecan + Temozolomide | N | N | 280028205 | IRINOTECAN + TEMOZOLOMIDE |
| 280011667 | 280005830 | null | 72.1 | Curative (C) | 2018-11-17 | 2018-11-17 | Cyclophosphamide oral | 2 | N | 280028214 | CYCLOPHOSPHAMIDE |
| 280011668 | 280010602 | 1.87 | 111 | Palliative (P) | 2018-05-22 | 2018-06-22 | Doxorubicin + Olaratumab | N | N | 280028217 | DOXORUBICIN + OLARATUMAB |
| 280011669 | 280005835 | null | 70.8 | Adjuvant (A) | 2017-02-09 | 2017-09-27 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | N | 280028240 | CETUXIMAB + CISPLATIN + FU |
| 280011670 | 280010605 | 1.8 | null | Palliative (P) | 2013-12-28 | 2014-01-13 | Cisplatin+Gemcitabine (gallbladder) | 02 | N | 280028255 | CISPLATIN + GEMCITABINE |
| 280011671 | 280005842 | 1.79 | 66 | Palliative (P) | 2013-08-30 | 2014-03-19 | DOXORUBICIN + IFOSFAMIDE | 01 | N | 280028259 | DOXORUBICIN + IFOSFAMIDE |
| 280011672 | 280010608 | 1.79 | 105.8 | Curative (C) | null | 2016-01-29 | Doxorubicin + Ifosfamide | null | null | 280028292 | DOXORUBICIN + IFOSFAMIDE |
| 280011673 | 280005857 | 1.61 | 76 | Curative (C) | 2014-06-01 | 2014-07-06 | CISPLATIN + FLUOROURACIL | N | N | 280028300 | CISPLATIN + FLUOROURACIL |
| 280011674 | 280005859 | 1.82 | 62.8 | Palliative (P) | 2014-03-09 | 2014-03-10 | Etoposide + Ifosfamide (3 days) | null | null | 280028302 | ETOPOSIDE + IFOSFAMIDE |
| 280011675 | 280009075 | 1.71 | 56.7 | Palliative (P) | 2019-01-04 | 2019-01-05 | Cyclophosphamide oral | Y | N | 280028320 | CYCLOPHOSPHAMIDE |
| 280011676 | 280005869 | 1.57 | 84.6 | Palliative (P) | 2014-11-02 | 2014-11-10 | Cisplatin +Fluorouracil (3 wk) | N | N | 280028322 | CISPLATIN + FLUOROURACIL |
| 280011677 | 280005873 | 1.64 | 113.4 | Neo-adjuvant (N) | 2017-04-07 | 2017-04-22 | VAC | N | N | 280028330 | CAV |
| 280011678 | 280010617 | 1.6 | null | Palliative (P) | 2017-02-20 | 2017-02-25 | Gemcitabine weekly | N | N | 280028345 | GEMCITABINE |
| 280011679 | 280005890 | null | 62 | Palliative (P) | null | 2018-07-05 | CISPLATIN + FLUOROURACIL | null | null | 280028408 | CISPLATIN + FLUOROURACIL |
| 280011680 | 280005897 | 1.64 | 68.9 | Palliative (P) | 2013-11-25 | 2013-11-25 | EW EuroEwing 2012 Arm A VIDE | 2 | N | 280028423 | EURO-EWING |
| 280011681 | 280005906 | 1.7 | 75.7 | Palliative (P) | 2018-12-08 | 2018-12-08 | CARBOPLATIN + ETOPOSIDE | 02 | N | 280028433 | CARBOPLATIN + ETOPOSIDE |
| 280011682 | 280010625 | 1.61 | 90.7 | Palliative (P) | 2018-03-31 | 2018-04-13 | Etoposide + Ifosfamide (3 days) | null | null | 280028455 | ETOPOSIDE + IFOSFAMIDE |
| 280011683 | 280011374 | 1.6 | 60 | Palliative (P) | 2015-10-06 | 2015-10-12 | CISPLATIN + FLUOROURACIL | 02 | null | 280028506 | CISPLATIN + FLUOROURACIL |
| 280011684 | 280005934 | null | 67 | Palliative (P) | 2017-11-09 | 2017-11-17 | FLUOROURACIL + OXALIPLATIN | N | N | 280028533 | OXALIPLATIN + MDG |
| 280011685 | 280009112 | 0 | 82.4 | Palliative (P) | 2015-08-31 | 2015-08-31 | Cetuximab+Cisplatin+FU (> Cycle 2) | 2 | N | 280028575 | CETUXIMAB + CISPLATIN + FU |
| 280011686 | 280005952 | 1.85 | 93 | Palliative (P) | 2014-01-20 | 2014-02-02 | DACTINOMYCIN + IFOSFAMIDE + MESNA + VINCRISTINE | N | N | 280028593 | IRINOTECAN + MDG |
| 280011687 | 280005958 | 1.86 | 119.3 | Curative (C) | 2017-11-22 | 2018-05-04 | Etoposide + Ifosfamide (3 days) | null | null | 280028610 | ETOPOSIDE + IFOSFAMIDE |
| 280011688 | 280005963 | 1.66 | 72.2 | Palliative (P) | 2017-07-14 | 2017-11-26 | CISPLATIN + FLUOROURACIL | N | N | 280028643 | CISPLATIN + FLUOROURACIL |
| 280011689 | 280012124 | 1.77 | 67.1 | Palliative (P) | 2017-05-07 | 2017-05-14 | Carboplatin + Etoposide iv&po | 02 | N | 280028678 | CARBOPLATIN + ETOPOSIDE |
| 280011690 | 280005979 | 1.74 | 67.3 | Palliative (P) | null | 2018-09-12 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 280028693 | GEMCITABINE |
| 280011691 | 280005980 | null | 58.5 | Palliative (P) | 2018-04-12 | 2018-12-10 | EW EuroEwing 99 : VIDE | N | N | 280028697 | EURO-EWING |
| 280011692 | 280005982 | 1.58 | null | Disease modification (D) | 2015-04-07 | 2015-06-29 | CISPLATIN + GEMCITABINE | Y | N | 280028706 | CISPLATIN + GEMCITABINE |
| 280011693 | 280010648 | 1.6 | 36.1 | Adjuvant (A) | 2014-06-15 | 2014-06-15 | Etoposide + Ifosfamide (3 days) | N | null | 280028712 | ETOPOSIDE + IFOSFAMIDE |
| 280011694 | 280012024 | 1.84 | 68 | Palliative (P) | 2016-05-25 | 2016-06-28 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | N | 280028766 | CETUXIMAB + CISPLATIN + FU |
| 280011695 | 280009145 | 1.49 | 68 | Palliative (P) | 2014-07-22 | 2014-12-28 | Oxaliplatin + Modified de Gramont | N | N | 280028813 | OXALIPLATIN + MDG |
| 280011696 | 280009150 | null | 46.6 | null | 2014-12-17 | 2015-01-13 | Etoposide + Ifosfamide (5 days) | 2 | N | 280028851 | ETOPOSIDE + IFOSFAMIDE |
| 280011697 | 280006026 | 1.74 | 116.5 | Palliative (P) | 2017-04-27 | 2017-05-24 | Cetuximab+Cisplatin+FU (> Cycle 2) | 02 | N | 280028860 | CETUXIMAB + CISPLATIN + FU |
| 280011698 | 280006031 | 1.63 | 60 | Palliative (P) | 2013-05-12 | 2013-11-15 | EW EuroEwing 2012 Arm A VIDE | N | N | 280028864 | EURO-EWING |
| 280011699 | 280006036 | 1.69 | 72 | Palliative (P) | 2017-09-09 | 2017-11-05 | CISPLATIN + GEMCITABINE | null | null | 280028879 | CISPLATIN + GEMCITABINE |
| 280011700 | 280006038 | 1.81 | 100.8 | Palliative (P) | 2017-06-12 | 2017-06-30 | Doxorubicin + Olaratumab | null | null | 280028918 | DOXORUBICIN + OLARATUMAB |
| 280011701 | 280011395 | 1.77 | 93.7 | Palliative (P) | 2016-06-21 | 2016-07-05 | Doxorubicin + Olaratumab | N | null | 280028929 | DOXORUBICIN + OLARATUMAB |
| 280011702 | 280009171 | 1.69 | null | Palliative (P) | 2017-08-07 | 2017-09-21 | Carboplatin + Etoposide iv&po | 02 | N | 280028989 | CARBOPLATIN + ETOPOSIDE |
| 280011703 | 280009174 | 1.72 | 64.3 | Palliative (P) | 2017-03-15 | 2017-04-03 | VAC | null | null | 280029001 | CAV |
| 280011704 | 280006060 | 1.8 | 102 | Palliative (P) | 2017-09-29 | 2018-05-13 | VAC | N | N | 280029009 | CAV |
| 280011705 | 280006067 | null | 76.05 | Palliative (P) | 2017-11-26 | 2018-02-20 | CETUXIMAB + CISPLATIN + FU | N | null | 280029015 | CETUXIMAB + CISPLATIN + FU |
| 280011706 | 280009180 | null | null | Palliative (P) | null | 2017-01-02 | Carboplatin + Etoposide IV 3 day | null | null | 280029021 | CARBOPLATIN + ETOPOSIDE |